Immunologic factors
Showing 1 - 25 of 3,534
Severe Mpox in Persons With Advanced HIV
Recruiting
- Monkeypox
- +2 more
-
Atlanta, GeorgiaCenters for Disease Control and Prevention
Sep 18, 2023
Genetic and Immunologic Characterization of IEI
Completed
- Immunity Disorders
- Inborn Errors of Immunity
-
Trieste, ItalyIRCCS materno infantile Burlo Garofolo
Apr 6, 2023
Dermal Hypersensitivity Reaction Trial in Ann Arbor (Dupilumab)
Not yet recruiting
- Dermal Hypersensitivity Reaction
-
Ann Arbor, MichiganUniversity of Michigan
Aug 21, 2023
HIV-1-infection Trial (Fostemsavir 600 MG [Rukobia])
Recruiting
- HIV-1-infection
- Fostemsavir 600 MG [Rukobia]
-
Orlando, FloridaOrlando Immunology Center
Sep 20, 2022
Pregnancy in Lung Transplantion : a National Multicentric Study
Not yet recruiting
- Lung Transplantation
- +2 more
- HLA typing of the children
- (no location specified)
Jan 16, 2023
Immunologic Signatures Following Surgery for Pancreatic Cancer
Active, not recruiting
- Pancreatic Cancer
- Surgery
-
Durham, North CarolinaDuke University Health System
Jun 24, 2022
Pancreatic Cancer, Cancer of the Pancreas, Pancreas Cancer Trial in Saint Louis (CDX-301, CDX-1140, Research blood draw)
Recruiting
- Pancreatic Cancer
- +2 more
- CDX-301
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 17, 2023
Myocarditis Trial
Recruiting
- Myocarditis
-
Paris, FranceHôpital Pitié-Salpêtrière
Sep 6, 2022
Covid19 Trial in Niagara, Toronto, Montreal (Omalizumab, Placebo)
Active, not recruiting
- Covid19
- Omalizumab
- Placebo
-
Niagara, Ontario, Canada
- +2 more
Nov 14, 2022
Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
Not yet recruiting
- Breast Carcinoma
- Invasive Breast Carcinoma
- Biopsy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 28, 2022
Adenomyosis Patients With Infertility and Immunological Factors
Not yet recruiting
- Adenomyosis
- Venous blood collection
- (no location specified)
Nov 8, 2023
Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)
Recruiting
- Glioblastoma
- +2 more
- TMZ
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Atopic Dermatitis Trial in Zürich (Application of Tralokinumab)
Not yet recruiting
- Atopic Dermatitis
- Application of Tralokinumab
-
Zürich, SwitzerlandAllergy Unit, Dept. of Dermatology, Unviersity Hosptial of Zuric
May 13, 2022
Mechanical Unloading on Repair Version-1
Completed
- Heart Failure
- Transplant; Failure, Heart
- (no location specified)
Sep 4, 2023
Natural History of Noncirrhotic Portal Hypertension
Recruiting
- Cystic Fibrosis
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 27, 2022
At-Home Subcutaneous Immunoglobulin Replacement Therapy Using
Not yet recruiting
- Primary Immunodeficiency Diseases (PID)
- No Intervention
- (no location specified)
Nov 21, 2023
Autoimmune Diseases, Lupus Erythematosus, Systemic, Communicable Diseases Trial in Atlanta
Enrolling by invitation
- Autoimmune Diseases
- +2 more
-
Atlanta, Georgia
- +2 more
May 17, 2022
Tests in the Diagnosis of COVID-19 in Pediatrics
Recruiting
- COVID-19
-
Trieste, ItalyIRCCS Burlo Garofolo
Mar 31, 2023
Asplenia Trial in Sacramento (Pneumovax-23)
Recruiting
- Asplenia
- Pneumovax-23
-
Sacramento, CaliforniaUniversity of California, Davis Medical Center
Jan 26, 2022
Corneal Endothelial Dystrophy, Corneal Edema Trial in Indianapolis (loteprednol etabonate 0.25% ophthalmic suspension)
Active, not recruiting
- Corneal Endothelial Dystrophy
- Corneal Edema
- loteprednol etabonate 0.25% ophthalmic suspension
-
Indianapolis, IndianaPrice Vision Group
Jan 6, 2023
Prediction of True Oligo-metastatic Disease.
Recruiting
- Oligometastatic Disease
- Genetic and immunologic assessments
-
Naples, ItalyAlessandro Ottaiano
Apr 7, 2023
Improvement of Immunologic and Molecular Techniques for
Not yet recruiting
- Acquired Thrombotic Thrombocytopenic Purpura
- ADAMTS13 Activity Assays
- (no location specified)
May 26, 2022
End Stage Renal Disease Trial in Lexington (Tacrolimus, Envarsus XR)
Recruiting
- End Stage Renal Disease
- Tacrolimus
- Envarsus XR
-
Lexington, KentuckyUniversity of Kentucky Transplant Center
Mar 11, 2022
Fallopian Tube Cancer, Fallopian Tube Infection Trial in Oklahoma City (Aspirin 81 mg)
Recruiting
- Fallopian Tube Cancer
- Fallopian Tube Infection
- Aspirin 81 mg
-
Oklahoma City, OklahomaStephenson Cancer Center, University of Oklahoma Health Sciences
Apr 11, 2022
Microbiome and Immunologic Analysis - Women With Endometriosis
Recruiting
- Endometriosis
- Tissue and blood collection
-
Rochester, MinnesotaMayo Clinic
Jan 3, 2022